Synalar and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Synalar (fluocinolone acetonide), especially for people who are female, 10-19 old, have been taking the drug for 2 - 5 years also take Elocon, and have Skin irritation.

The phase IV clinical study analyzes which people have Rashes when taking Synalar. It is created by eHealthMe based on reports of 328 people who have side effects when taking Synalar from the FDA, and is updated regularly.

What is Synalar?

Synalar has active ingredients of fluocinolone acetonide. eHealthMe is studying from 332 Synalar users. Check the latest studies of Synalar.

What is Rashes?

Rashes (redness) is found to be associated with 3,715 drugs and 6,216 conditions by eHealthMe. Check the latest studies of Rashes.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

328 people reported to have side effects when taking Synalar.
Among them, 31 people (9.45%) have Rashes.

Among these 31 people:

How long have people been on Synalar when they have Rashes? *

What is the gender of people who have Rashes when taking Synalar? *

female: 68.97 %
male: 31.03 %

What is the age of people who have Rashes when taking Synalar? *

What are other drugs people take besides Synalar? *

Elocon: 6 people, 19.35%
Protopic: 5 people, 16.13%
Humira: 4 people, 12.90%
Novorapid: 4 people, 12.90%
Phyllocontin: 4 people, 12.90%
Lantus: 4 people, 12.90%
Movicol: 3 people, 9.68%
Triamcinolone Acetonide: 3 people, 9.68%
Clobetasol Propionate: 2 people, 6.45%
Ketoconazole: 2 people, 6.45%

What are other side effects people have besides Rashes? *

Itching: 15 people, 48.39%
Skin Exfoliation (removal of the oldest dead skin cells): 11 people, 35.48%
Swelling: 10 people, 32.26%
Steroid Withdrawal Syndrome (dizziness, fatigue, gastrointestinal problems, and headaches after stop taking steroids): 9 people, 29.03%
Pain: 9 people, 29.03%
Insomnia (sleeplessness): 8 people, 25.81%
Burning Sensation: 7 people, 22.58%
Skin Disorder (skin disease): 6 people, 19.35%
Neurological Symptom (symptoms of nervous system disease): 6 people, 19.35%
Hypersensitivity: 6 people, 19.35%

What are the existing conditions these people have? *

Skin Irritation: 6 people, 19.35%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 5 people, 16.13%
Diarrhea: 4 people, 12.90%
Vasculitis (inflammation of a blood vessel or blood vessels): 3 people, 9.68%
Localised Infection (infection at the single location): 3 people, 9.68%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 9.68%
Fungal Infection: 3 people, 9.68%
Granuloma (a small area of inflammation due to tissue injury): 3 people, 9.68%
Hypophagia (reduced food intake): 3 people, 9.68%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Synalar and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Synalar:

Synalar (332 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Synalar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,715 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,216 conditions)

Related publications that referenced our studies

Telfer SJ, "Fluoroquinolone antibiotics and type 2 diabetes mellitus", Medical hypotheses, 2014 Sep .
Telfer SJ, "Fluoroquinolone antibiotics and type 2 diabetes mellitus", Medical hypotheses, 2014 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on fluocinolone acetonide (the active ingredients of Synalar) and Synalar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.